Goldman Sachs’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-157,910
| Closed | -$117K | – | 5313 |
|
|
2022
Q3 | $117K | Sell |
157,910
-1,886
| -1% | -$1.4K | ﹤0.01% | 4884 |
|
|
2022
Q2 | $124K | Sell |
159,796
-616,139
| -79% | -$478K | ﹤0.01% | 5058 |
|
|
2022
Q1 | $702K | Sell |
775,935
-3,137,459
| -80% | -$2.84M | ﹤0.01% | 4368 |
|
|
2021
Q4 | $31.3M | Buy |
3,913,394
+481,325
| +14% | +$3.86M | 0.01% | 1441 |
|
|
2021
Q3 | $28.7M | Buy |
3,432,069
+99,499
| +3% | +$833K | 0.01% | 1467 |
|
|
2021
Q2 | $22.5M | Buy |
3,332,570
+20,063
| +0.6% | +$135K | 0.01% | 1654 |
|
|
2021
Q1 | $21.9M | Buy |
3,312,507
+21,472
| +0.7% | +$142K | 0.01% | 1619 |
|
|
2020
Q4 | $13.8M | Sell |
3,291,035
-25,802
| -0.8% | -$108K | ﹤0.01% | 1832 |
|
|
2020
Q3 | $15.9M | Sell |
3,316,837
-1,537
| -0% | -$7.36K | ﹤0.01% | 1636 |
|
|
2020
Q2 | $20.2M | Sell |
3,318,374
-3,329
| -0.1% | -$20.2K | 0.01% | 1474 |
|
|
2020
Q1 | $18.2M | Sell |
3,321,703
-28,489
| -0.9% | -$156K | 0.01% | 1383 |
|
|
2019
Q4 | $33.2M | Buy |
3,350,192
+28,085
| +0.8% | +$278K | 0.01% | 1280 |
|
|
2019
Q3 | $19.1M | Sell |
3,322,107
-21,215
| -0.6% | -$122K | 0.01% | 1551 |
|
|
2019
Q2 | $30.4M | Sell |
3,343,322
-187,246
| -5% | -$1.7M | 0.01% | 1325 |
|
|
2019
Q1 | $49M | Buy |
3,530,568
+124,466
| +4% | +$1.73M | 0.01% | 1028 |
|
|
2018
Q4 | $53.7M | Buy |
+3,406,102
| New | +$53.7M | 0.02% | 909 |
|
|
2015
Q4 | – | Sell |
-11,135
| Closed | -$162K | – | 4576 |
|
|
2015
Q3 | $162K | Sell |
11,135
-138
| -1% | -$2.01K | ﹤0.01% | 3956 |
|
|
2015
Q2 | $188K | Sell |
11,273
-7,776
| -41% | -$130K | ﹤0.01% | 4042 |
|
|
2015
Q1 | $417K | Buy |
19,049
+7,779
| +69% | +$170K | ﹤0.01% | 3434 |
|
|
2014
Q4 | $244K | Buy |
+11,270
| New | +$244K | ﹤0.01% | 3836 |
|